0B68 Merli, Geno S. - Thomas Jefferson University - Thomas Jefferson University

Geno J. Merli, MD

Contact Dr Merli

111 S. 11th Street
Gibbon Building, Ste. 6270
Philadelphia, PA 19107

(215) 955-6540
(215) 923-0835 fax

Most Recent Peer-reviewed Publications

  1. The Consult Guys - atrial fibrillation: how controlled is well-controlled?
  2. The consult guys: hyperglycemia: am I a control freak?
  3. Evaluation of the oral direct factor Xa inhibitor-betrixaban
  4. The consult guys: green urine?!?
  5. Venous thromboembolism prevention guidelines for medical inpatients: Mind the (implementation) Gap
  6. The consult guys: perioperative risk assessment: can you get it right?
  7. The consult guys: a 23-year-old with a myocardial infarction: will you get the right diagnosis?
  8. Erratum: Implications of new anticoagulants in primary practice (Psycho-Oncology (2013) 67 (139-156))
  9. New oral anticoagulants: Prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients
  10. Delivery of optimized inpatient anticoagulation therapy: Consensus statement from the anticoagulation forum | Terapia de anticoagulación optimizada en el paciente hospitalizado: Declaración de consenso del Foro de Anticoagulación
  11. Novel anticoagulant use for venous thromboembolism: A 2013 update
  12. Rivaroxaban for thromboprophylaxis in acutely ill medical patients
  13. Implications of new anticoagulants in primary practice
  14. Implementing the new oral anticoagulants into the hospital formulary
  15. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients
  16. Newer Oral Anticoagulants
  17. Performance measures for improving the prevention of venous thromboembolism: Achievement in clinical practice
  18. Predictive and associative models to identify hospitalized medical patients at risk for VTE
  19. Prophylaxis for Deep Vein Thrombosis and Pulmonary Embolism in the Surgical Patient
  20. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis